Effect of baseline Alberta Stroke Program Early CT Score on safety and efficacy of intra-arterial treatment: a subgroup analysis of a randomised phase 3 trial (MR CLEAN)

Albert J. Yoo, Olvert A. Berkhemer, Puck S. S. Fransen, Lucie A. van den Berg, Debbie Beumer, Hester F. Lingsma, Wouter J. Schonewille, Marieke E. S. Sprengers, Rene van den Berg, Marianne A. A. van Walderveen, Ludo F. M. Beenen, Marieke J. H. Wermer, Geert J. Lycklama a Nijeholt, Jelis Boiten, Sjoerd F. M. Jenniskens, Joseph C. J. Bot, Anna M. M. Boers, Henk A. Marquering, Yvo B. W. E. M. Roos, Robert J. van OostenbruggeDiederik W. J. Dippel, Aad van der Lugt, Wim H. van Zwam, Charles B. L. M. Majoie

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)685-694
JournalLancet Neurology
Volume15
Issue number7
DOIs
Publication statusPublished - Jun 2016

Cite this

Yoo, A. J., Berkhemer, O. A., Fransen, P. S. S., van den Berg, L. A., Beumer, D., Lingsma, H. F., Schonewille, W. J., Sprengers, M. E. S., van den Berg, R., van Walderveen, M. A. A., Beenen, L. F. M., Wermer, M. J. H., Nijeholt, G. J. L. A., Boiten, J., Jenniskens, S. F. M., Bot, J. C. J., Boers, A. M. M., Marquering, H. A., Roos, Y. B. W. E. M., ... Majoie, C. B. L. M. (2016). Effect of baseline Alberta Stroke Program Early CT Score on safety and efficacy of intra-arterial treatment: a subgroup analysis of a randomised phase 3 trial (MR CLEAN). Lancet Neurology, 15(7), 685-694. https://doi.org/10.1016/S1474-4422(16)00124-1